These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10147)

  • 21. Transfer of naltrexone and its metabolite 6,beta-naltrexol into human milk.
    Chan CF; Page-Sharp M; Kristensen JH; O'Neil G; Ilett KF
    J Hum Lact; 2004 Aug; 20(3):322-6. PubMed ID: 15296587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testing of drug delivery systems for use in the treatment of narcotic addiction.
    Reuning RH; Malspeis L; Frank S; Notari RE
    Natl Inst Drug Abuse Res Monogr Ser; 1976 Jan; (4):43-5. PubMed ID: 823438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disposition of (15,16-3H)naltrexone in the central nervous system of the rat.
    Misra AL; Bloch R; Vardy J; Mulé SJ; Verebely K
    Drug Metab Dispos; 1976; 4(3):276-80. PubMed ID: 6233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Naltrexone metabolism and sustained release following administration of an insoluble complex to rhesus monkeys and guinea-pigs.
    Macgregor TR; Drum MA; Harrigan SE; Wiley JN; Reuning RH
    J Pharm Pharmacol; 1983 Jan; 35(1):38-42. PubMed ID: 6131962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum 6-beta-naltrexol levels are related to alcohol responses in heavy drinkers.
    McCaul ME; Wand GS; Rohde C; Lee SM
    Alcohol Clin Exp Res; 2000 Sep; 24(9):1385-91. PubMed ID: 11003204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single- and multiple-dose pharmacokinetics of long-acting injectable naltrexone.
    Dunbar JL; Turncliff RZ; Dong Q; Silverman BL; Ehrich EW; Lasseter KC
    Alcohol Clin Exp Res; 2006 Mar; 30(3):480-90. PubMed ID: 16499489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analytical methods for quantitative and qualitative analysis of naltrexone and metabolites in biological fluids.
    Wall ME; Brine DR
    NIDA Res Monogr; 1981; 28():52-65. PubMed ID: 6791013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of naltrexone and 6-beta-naltrexol in human plasma following implantation of naltrexone pellets using gas chromatography-mass spectrometry.
    Toennes SW; Kauert GF; Grüsser SM; Jäkel W; Partecke G
    J Pharm Biomed Anal; 2004 Apr; 35(1):169-76. PubMed ID: 15030891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The stimulatory effect of morphine on reduction of naltrexone to 6 alpha-naltrexol in the guinea pig.
    Roerig SC; Fujimoto JM; Wang RI
    Drug Metab Dispos; 1980; 8(5):295-9. PubMed ID: 6107224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous analysis of naltrexone and its major metabolite, 6-beta-naltrexol, in human plasma using liquid chromatography-tandem mass spectrometry: Application to a parent-metabolite kinetic model in humans.
    Yun HY; Bang SC; Lee KC; Baek IH; Lee SP; Kang W; Kwon KI
    Talanta; 2007 Mar; 71(4):1553-9. PubMed ID: 19071491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo and in vitro potency studies of 6beta-naltrexol, the major human metabolite of naltrexone.
    Porter SJ; Somogyi AA; White JM
    Addict Biol; 2002 Apr; 7(2):219-25. PubMed ID: 12006217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxymorphone metabolism and urinary excretion in human, rat, guinea pig, rabbit, and dog.
    Cone EJ; Darwin WD; Buchwald WF; Gorodetzky CW
    Drug Metab Dispos; 1983; 11(5):446-50. PubMed ID: 6194952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Excretion and metabolism of recainam, a new anti-arrhythmic drug, in laboratory animals and humans.
    Scatina JA; Wells DS; Kimmel HB; Kemper CJ; Sisenwine SF
    Drug Metab Dispos; 1990; 18(5):746-52. PubMed ID: 1981731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative determination of 2-hydroxy-3-methoxy-6 beta-naltrexol (HMN), naltrexone, and 6 beta-naltrexol in human plasma, red blood cells, saliva, and urine by gas liquid chromatography.
    Verebey K; De Pace A; Jukofsky D; Volavka JV; Mulé SJ
    J Anal Toxicol; 1980; 4(1):33-7. PubMed ID: 6927049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolism of labetalol by animals and man.
    Martin LE; Hopkins R; Bland R
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Species differences in the metabolism and disposition of spironolactone.
    Karim A; Kook C; Zitzewitz DJ; Zagarella J; Doherty M; Campion J
    Drug Metab Dispos; 1976; 4(6):547-55. PubMed ID: 11976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biotransformation of nevirapine, a non-nucleoside HIV-1 reverse transcriptase inhibitor, in mice, rats, rabbits, dogs, monkeys, and chimpanzees.
    Riska PS; Joseph DP; Dinallo RM; Davidson WC; Keirns JJ; Hattox SE
    Drug Metab Dispos; 1999 Dec; 27(12):1434-47. PubMed ID: 10570025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The metabolism of zomepirac sodium. I. Disposition in laboratory animals and man.
    Grindel JM; O'Neill PJ; Yorgey KA; Schwartz MH; McKown LA; Migdalof BH; Wu WN
    Drug Metab Dispos; 1980; 8(5):343-8. PubMed ID: 6107233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of nisoldipine. III. Biotransformation of nisoldipine in rat, dog, monkey, and man.
    Scherling D; Karl W; Ahr G; Ahr HJ; Wehinger E
    Arzneimittelforschung; 1988 Aug; 38(8):1105-10. PubMed ID: 2973788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The metabolism of [14C]rimantadine hydrochloride in rats and dogs.
    Loh AC; Szuna AJ; Williams TH; Sasso GJ; Leinweber FJ
    Drug Metab Dispos; 1991; 19(2):381-7. PubMed ID: 1676641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.